Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Recruiting 3Completed 1

Sponsor Class

OTHER 9INDUSTRY 4NIH 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Genitourinary 22Gynecologic 4Lymphoid 1Head & Neck 1Dermatologic 1Breast 1

Conditions

Ovarian Neoplasms 1006Uterine Cervical Neoplasms 420Endometrial Neoplasms 350Carcinoma, Non-Small-Cell Lung 292Breast Neoplasms 292Neoplasms 238Colorectal Neoplasms 233Fallopian Tube Neoplasms 211Stomach Neoplasms 192Pancreatic Neoplasms 184Melanoma 157Prostatic Neoplasms 152Triple Negative Breast Neoplasms 148Carcinoma, Ovarian Epithelial 147Lung Neoplasms 136Neoplasm Metastasis 133Squamous Cell Carcinoma of Head and Neck 131Carcinoma, Renal Cell 130Head and Neck Neoplasms 122Esophageal Neoplasms 121Urinary Bladder Neoplasms 112Small Cell Lung Carcinoma 90Sarcoma 80Carcinoma, Hepatocellular 76Recurrence 70Carcinoma, Transitional Cell 70Uterine Cervical Dysplasia 66Papillomavirus Infections 66Colonic Neoplasms 59Cholangiocarcinoma 59

Interventions

cemiplimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Carcinoma in Situ × Gynecologic × Clear all
NCT06022029 2025-12-24

ON-5001

OncoNano Medicine, Inc.

Phase 1 Recruiting
168 enrolled
BreastDermatologicGenitourinaryGynecologicHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Bites and Stings, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma in Situ, Uterine Cervical Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Neoplasm Metastasis, Neoplasms, Recurrence, Skin Neoplasms, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Triple Negative Breast Neoplasms

NCT07092007 2025-07-29

NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer

Newish Technology (Beijing) Co., Ltd.

Phase NA Recruiting
18 enrolled
Gynecologic

Carcinoma in Situ, Uterine Cervical Neoplasms

NCT06741150 2024-12-18

NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients.

Newish Technology (Beijing) Co., Ltd.

Phase NA Recruiting
18 enrolled
Gynecologic

Carcinoma in Situ, Uterine Cervical Neoplasms

NCT04312737 2023-01-06

EU-VALHUDES

Hiantis Srl

Completed
600 enrolled
Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Neoplasms, Neoplasms by Histologic Type

Data powered by HemOnc (CC BY 4.0) Colophon âš¡